Effect of BMP-12, TGF-β1 and autologous conditioned serum on growth factor expression in Achilles tendon healing
Achilles tendon ruptures are devastating and recover slowly and incompletely. There is a great demand for biomolecular therapies to improve recovery, yet little is understood about growth factors in a healing tendon. Here, the role of growth factors during tendon healing in a rat model and their reaction to single and multiple growth factor treatment are explored.
Rat tendons were transected surgically and resutured. The expression of bFGF, BMP-12, VEGF and TGF-β1 was assessed by immunohistochemical analysis one to 8 weeks after surgery. Paracrine effects of TGF-β1 or BMP-12 added by adenoviral transfer, as well as the effect of autologous conditioned serum (ACS) on growth factor expression, were evaluated.
bFGF, BMP-12 and VEGF expression was highest 1 week after transection. bFGF and BMP-12 declined during the remaining period whereas VEGF expression persisted. TGF-β1 expression dramatically increased after 8 weeks. ACS treatment increased bFGF (P = 0.007) and BMP-12 (P = 0.004) expression significantly after 8 weeks. Also overall expression of bFGF, BMP-12 and TGF-β1 regardless of time point was significantly greater than controls with ACS treatment (P < 0.05). Both BMP-12 and TGF-β1 treatments had no significant effect. No effect was observed in VEGF with any treatment.
bFGF, BMP-12, VEGF and TGF-β1 are differentially expressed during tendon healing. Additional BMP-12 or TGF-β1 has no significant influence, whereas ACS generally increases expression of all factors except VEGF. Staged application of multiple growth factors may be the most promising biomolecular treatment.
KeywordsGrowth factors Tendon healing Biological repair Animal model
Autologous conditioned serum
Basic fibroblast growth factor, a.k.a. FGF-2
Bone morphogenic protein
Cartilage-derived morphogenic protein
Growth and differentiation factor
Insulin-like growth factor 1
Platelet-derived growth factor
Transforming growth factor beta 1
Vascular endothelial growth factor
- 4.Fabricius E, Kruse-Boitschenko U, Khoury R, Wildner G, Raguse J, Klein M (2009) Immunohistochemical determination of the appropriate anti-hTERT antibodies for in situ detection of telomerase activity in frozen sections of head and neck squamous cell carcinomas and tumor margin tissues. Int J Oncol 34(5):1257–1279PubMedGoogle Scholar
- 10.Ide J, Kikukawa K, Hirose J, Iyama K, Sakamoto H, Fujimoto T, Mizuta H (2009) The effect of a local application of fibroblast growth factor-2 on tendon-to-bone remodeling in rats with acute injury and repair of the supraspinatus tendon. J Shoulder Elbow Surg 18(3):391–398PubMedCrossRefGoogle Scholar
- 25.Otoshi K, Kikuchi S, Ohi G, Numazaki H, Sekiguchi M, Konno S (2011) The process of tendon regeneration in an Achilles tendon resection rat model as a model for hamstring regeneration after harvesting for anterior cruciate ligament reconstruction. Arthroscopy 27(2):218–227PubMedCrossRefGoogle Scholar
- 28.Remmele W, Stegner HE (1987) Vorschlag zur einheitlichen Definition eines immunreaktiven Scores (IRS) für den imunhistochemischen Östrogenrezeptornachweis (ER-ICA) in Mammagewebe. [Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue]. Pathologe 8(3):138–140PubMedGoogle Scholar
- 29.Rickert M (2008) BMP-14 gene therapy increases tendon tensile strength in a rat model of Achilles tendon injury. J Bone Jt Surg Am 90(2):445–446Google Scholar
- 30.Rodeo SA, Seneviratne A, Suzuki K, Felker K, Wickiewicz TL, Warren RF (2000) Histological analysis of human meniscal allografts. A preliminary report. J Bone Jt Surg Am 82-A (8):1071–1082Google Scholar
- 31.Schippinger G, Oettl K, Fankhauser F (2011) Influence of intramuscular application of autologous conditioned plasma on systemic circulating IGF-1. J Sports Sci Med 2011(10):439–444Google Scholar